SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
Instagram Outage Disrupts Thousands of U.S. Users 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Dublin, March 11, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/rhvbfw/metered_dose) has announced the addition of the "Metered Dose Inhalers to 2022" report to their offering.
This report examines the current and future metered dose inhalers market and the key topics all market participants should be aware of. Recent improvements in the control of the inspiry event have reduced the need for add-on devices designed to help regulate patient administration. Growth in upper airway therapeutics will help to push MDI unit demand to high single digits between now and the end of the decade.
Questions Answered:
- What inhalable drugs are supplied in MDIs, how are they marketed, what are the device specifics, and who markets them?
- What inhalable MDI products are in late stage development, who are the developers, and what indications are they targeting?
- What are the major factors driving metered dose inhaled drug/device demand?
- What is the size of the market today, who are the market share leaders, and what will the market share be in 2022?
- How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
- What are the essential design factors, material selection issues, technologies and market development issues MDI products?
- What are the significant economic, technology, and regulatory factors affecting the market for MDIs?
Report Structure:
1. Executive Summary
2. Inhaled Drug Delivery Market Dynamics
3. Devices and Formulations
4. MDI Technology Factors
5. MDI Performance Factors
6. MDI Product Assessments and Analysis
7. Therapeutic Market Analysis, Market Data and Forecasts
8. Market Factors
9. Company Profiles
For more information visit http://www.researchandmarkets.com/research/rhvbfw/metered_dose
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Inhalers and Nebulisers, Respiratory Devices
